Clinical trial
Study of the Relationship Between rHuEPO Dose, Serum ADPN, and Mortality in…
NCT00308698 · Hamamatsu University, Other · Completed
Key facts
| NCT number | NCT00308698 |
|---|---|
| Title | Study of the Relationship Between rHuEPO Dose, Serum ADPN, and Mortality in Patients Beginning Hemodialysis (HD) |
| Official title | Recombinant Human Erythropoietin Dose, Serum Adiponectin, and All-Cause Mortality in Patients Beginning Hemodialysis |
| Lead sponsor | Hamamatsu University, Other |
| Collaborators | Fujinomiya City Hospital Iwata City Hospital Seirei Mikatabara General Hospital Seirei Hamamatsu General Hospital Hamana Clinic Tadokoro Clinic Makoto Clinic Maruyama Memorial General Hospital Shitoro… |
| Status | Completed |
| Study type | Observational |
| Conditions | Renal Dialysis |
| First posted | Mar 30, 2006 |
| Last update posted | Mar 30, 2006 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: